Breaking
Sunday, June 14, 2026

Press Releases

🇺🇸 FDA

FDA news and analysis for pharmaceutical BD, investment, and market access

Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.

Showing 1–12 of 212 articles

Quick answer

Track 212 FDA pharmaceutical press releases and corporate announcements — product launches, trial updates, partnerships, and regulatory milestones. Each story links to company profiles, pipeline programs, and related market intelligence for BD and investor due diligence.

High impact NewsJun 3, 2026

NIH Funding Cuts Hamper Ebola Preparedness and Global Health Security

NIH · Ebola · 6 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

How one state’s medical meal program lowered health care costs

8 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

CMS Finalizes Medicaid Work Requirement Rules, Impacting State Programs and Pharma Strategy

CMS · 7 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 27, 2026

Kailera’s Three-Pronged Obesity Shot Shows Promise in Early Trial

obesity · 2 min

Dr. Sarah Mitchell
High impact NewsMay 13, 2026

Novo Nordisk Reports Record Q1 Revenue Driven by Wegovy and Ozempic Demand

EMA · 2 min

Dr. Sarah Mitchell
High impact NewsMay 5, 2026

Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas

2 min

Michael Rivera
High impact NewsMay 5, 2026

Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment

2 min

Dr. Natalie Hughes
High impact NewsMay 5, 2026

CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis

2 min

Dr. Sarah Mitchell
Critical impact NewsMay 5, 2026

Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD

FDA · 2 min

Dr. Priya Nandakumar
High impact NewsMay 5, 2026

Cellenkos Receives FDA Clearance for CK0802 Phase 1b/2a Trial in Steroid-Refractory GVHD

FDA · 2 min

James Chen, PharmD
Critical impact NewsMay 5, 2026

FDA Approves Guardant360 CDx Companion Diagnostic for Pfizer's VEPPANU in ER+/HER2- Breast Cancer

FDA · 2 min

Michael Rivera
High impact NewsMay 5, 2026

Opus Genetics' OPGx-LCA5 Gene Therapy Accepted Into FDA's Rare Disease Evidence Program

FDA · 2 min

Dr. Natalie Hughes

Frequently asked questions

What counts as a press release on NovaPharmaNews?

Corporate announcements from pharma and biotech sponsors — FDA/EMA milestones, trial initiations, financing, licensing deals, and product launches — tagged to the press releases topic and cross-linked to company entity profiles where available.

How is this different from drug approval news?

Drug approval coverage focuses on regulatory decisions and label changes. Press releases capture sponsor-issued announcements, which may precede or supplement formal agency actions.

Can I find press releases by company?

Open any article to see linked company names, then follow through to the company directory profile for pipeline, drugs, patents, and related news.